表紙:抗肥満薬の中国市場
市場調査レポート
商品コード
86346

抗肥満薬の中国市場

Anti-Obesity Drugs Markets in China

出版日: | 発行: Asia Market Information & Development Co. | ページ情報: 英文 211 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
抗肥満薬の中国市場
出版日: 2023年11月27日
発行: Asia Market Information & Development Co.
ページ情報: 英文 211 Pages
納期: 即納可能 即納可能とは
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、中国の抗肥満薬市場について調査分析し、需要と業界動向の予測や、事業環境、市場参入についての情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲と調査手法
  • エグゼクティブサマリー

第2章 事業環境

  • 経済の見通し
  • 主要経済指標
  • 業界の販売量
  • 人口と労働力
  • 外国投資
  • 外国貿易
  • 財務と税金の規制
  • 銀行システムと規制
  • 外国為替
  • 税金と関税

第3章 抗肥満薬業界の評価

  • 抗肥満薬業界の構造
  • 市場規模
  • 市場の成長促進要因
  • 抗肥満薬業界
  • 主な生産施設の場所と販売量
  • 場所
  • 販売量
  • 主要生産者の市場シェア
  • 人件費
  • 潜在的な参入企業
  • 主な販売業者
  • 主な海外投資
  • 技術開発

第4章 抗肥満薬の生産と需要

  • 概要
  • 抗肥満薬の需要:地域別
  • 抗肥満薬の生産と需要
  • シブトラミン
  • 漢方薬
  • オルリスタット
  • リモナバント
  • メトホルミン
  • その他の抗肥満薬
  • 抗肥満薬の輸出入
  • 価格動向

第5章 抗肥満薬市場の見通し

  • 抗肥満薬市場の見通しの概要
  • 政府の規制
  • 医療保険業界の概要
  • 消費動向
  • 人口動態の動向
  • 医療業界の動向
  • 病院と病床
  • 医師と受診

第6章 マーケティング戦略

  • 中国市場参入の概要
  • 中国の流通システム
  • 抗肥満薬の流通チャネル
  • 輸送と貨物のインフラ
  • コミュニケーション
  • 中国市場参入
  • ライセンシング
  • フランチャイズ
  • eコマース
  • 商社と現地の代理店
  • 駐在員事務所と中国の子会社
  • 完全外資企業

第7章 抗肥満薬生産者ディレクトリ

  • 抗肥満薬の生産者と主要サプライヤーのプロファイル
図表

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Sales Volume
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ANTI-OBESITY TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Anti-Obesity Drugs Industry Sales Volume
  • Major Producer Facility Location
  • Major Anti-Obesity Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Anti-Obesity Drugs Production and Demand
  • Demand of Anti-Obesity Drugs by Region
  • Major Sibutramine Producer Sales Volume
  • Sibutramine Drugs Production and Demand
  • Major Traditional Chinese medicine Producer Sales Volume
  • Traditional Chinese Medicine Production and Demand
  • Major Orlistat Producer Sales Volume
  • Olistat Production and Demand
  • Rimonabant Production and Demand
  • Major Metformin Producer Sales Volume
  • Metformin Production and Demand
  • Other Anti-obesity Drugs Production and Demand
  • China Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Total Anti-Obesity Drugs Sales Volume by Market
  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • China's Anti-Obesity Drugs Sales Volume, Demand

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Sales Volume by Ownership
  • China's Imports and Exports

III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

  • All kinds of Anti-Obesity Drugs Market Share
  • Anti-Obesity Drugs Sales Volume and Demand

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Total Anti-Obesity Drugs Production and Demand
  • Total Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Anti-Obesity Drugs Sales Volume by Market

VI. MARKETING STRATEGIES

  • China's Distribution Channel
目次
Product Code: 810

China's demand for Anti-Obesity Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary
  • II.BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Sales Volume
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

  • Anti-Obesity Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Anti-Obesity Drugs Industry
  • Major Producer Facility Locations and Sales Volume
  • Locations
  • Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Anti-Obesity Drugs by Region
  • Anti-Obesity Drugs Production and Demand
  • Sibutramine
  • Major Manufacturers
  • Supply and Demand
  • Traditional Chinese Medicine
  • Major Manufacturers
  • Supply and Demand
  • Orlistat
  • Major Manufacturers
  • Supply and Demand
  • Rimonabant
  • Major Manufacturers
  • Supply and Demand
  • Metformin
  • Major Manufacturers
  • Supply and Demand
  • Other Anti-Obesity Drugs
  • Anti-Obesity Drugs Imports and Exports
  • Anti-Obesity Drugs Imports
  • Anti-Obesity r Drugs Exports
  • Pricing Trend

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Anti-Obesity Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ANTI-OBESITY DRUGS PRODUCER DIRECTORY

  • Profiles of Anti-Obesity Drugs Producers and Major Suppliers